Heritage Optical Center Inc - Medicare Optometrist in Detroit, MI

Heritage Optical Center Inc is a medicare enrolled "Optometrist" provider in Detroit, Michigan. Their current practice location is 19010 Livernois Ave, Detroit, Michigan. You can reach out to their office (for appointments etc.) via phone at (313) 863-9581.

Heritage Optical Center Inc is licensed to practice in Michigan (license number 4601003146) and it also participates in the medicare program. Heritage Optical Center Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1285728964.

Contact Information

Heritage Optical Center Inc
19010 Livernois Ave,
Detroit, MI 48221-2259
(313) 863-9581
(313) 863-7710



Healthcare Provider's Profile

Full NameHeritage Optical Center Inc
TypeFacility
SpecialityOptometrist
Location19010 Livernois Ave, Detroit, Michigan
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1285728964
  • Provider Enumeration Date: 10/03/2006
  • Last Update Date: 12/20/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 1052408986
  • Enrollment ID: O20071024000612

Medical Identifiers

Medical identifiers for Heritage Optical Center Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1285728964NPI-NPPES
2831091MedicaidMI
4971556MedicaidMI
5102658MedicaidMI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4601003146 (Michigan)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Heritage Optical Center Inc acts as a billing entity for following providers:
Provider NameLanny Green
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1972557858
PECOS PAC ID: 3072588193
Enrollment ID: I20060110000662

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameRovetta Mattia
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1366497661
PECOS PAC ID: 7416969555
Enrollment ID: I20060608000113

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameBradley Habermehl
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1356375463
PECOS PAC ID: 2365443314
Enrollment ID: I20070118000342

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameDawn Kathleen Caldwell
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1649311697
PECOS PAC ID: 0941308522
Enrollment ID: I20070605000418

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameLaura J Bahorski
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1932249091
PECOS PAC ID: 7911007315
Enrollment ID: I20070714000060

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameRobert T Kocembo
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1730118878
PECOS PAC ID: 7214024009
Enrollment ID: I20071025000417

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameRobert E Deck
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1437177342
PECOS PAC ID: 0648386862
Enrollment ID: I20130606000550

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameJennifer N Dudovitz
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1790720225
PECOS PAC ID: 3870864929
Enrollment ID: I20170808000752

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameFatima Karim
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1538545611
PECOS PAC ID: 1850641333
Enrollment ID: I20180904001812

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameKatherine Anderson
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1124500699
PECOS PAC ID: 1951733070
Enrollment ID: I20191112000458

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameAlexandra D Heisler
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1922411651
PECOS PAC ID: 1850698374
Enrollment ID: I20200813000522

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameChisom O Chukwumerije
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1275114837
PECOS PAC ID: 8426448358
Enrollment ID: I20220613001869

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameTiffany Marcoe
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1083182950
PECOS PAC ID: 8921347303
Enrollment ID: I20220920000640

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameIqjyot K Gill
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1851053003
PECOS PAC ID: 0749657708
Enrollment ID: I20221103001367

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameWassim H Fakih
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1396443206
PECOS PAC ID: 4082070248
Enrollment ID: I20230515002329

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Provider NameAl'tiana Manning
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1821615873
PECOS PAC ID: 5092103408
Enrollment ID: I20231019002984

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Heritage Optical Center Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Heritage Optical Center Inc
19010 Livernois Ave,
Detroit, MI 48221-2259

Ph: (313) 863-9581
Heritage Optical Center Inc
19010 Livernois Ave,
Detroit, MI 48221-2259

Ph: (313) 863-9581

News Archive

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called "2.6g 329m/s" takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that its investigational biopharmaceutical product, MP4CO, has been awarded orphan drug designation by the U.S. Food and Drug Administration (FDA) for use in treating acute painful sickling crises in patients with sickle cell disease.

Smoking intensity affects course of bladder cancer

Smoking not only causes bladder cancer—it also affects its course, in that people who smoke more have greater likelihood of developing more aggressive and deadly disease. That is one of the conclusions of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study also found that a panel of bladder cancer markers can predict which particular cases are at the highest risk for a fatal outcome.

Outcome-based contract between CIGNA and Merck helps diabetics control blood sugar levels

The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.

HCV testing and treatment at federally qualified health centers can be cost-fffective

New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.

Read more News

› Verified 7 days ago


Optometrist in Detroit, MI

Dr. Robert Fredrick Lee Iii, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 15157 Gratiot Ave, Detroit, MI 48205
Phone: 313-526-7664    Fax: 313-526-2055
Dr. Sura Hassan, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 4717 St. Antoine, Kresge Eye Institute, Detroit, MI 48201
Phone: 313-577-8900    Fax: 313-577-0700
Dr. Richard Edwin Gay, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 19173 Mack Ave, Detroit, MI 48230
Phone: 313-882-7883    Fax: 313-882-5128
Heritage Optical Inc.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2678 E Jefferson Ave, Detroit, MI 48207
Phone: 313-259-6006    
Dr. Linda Le,
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1301 Orleans St Apt 1705, Detroit, MI 48207
Phone: 248-759-9202    
Wayne State University Physician Group
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 4717 Saint Antoine St, Detroit, MI 48201
Phone: 313-577-8900    Fax: 313-577-0700
Heritage Optical Center, Inc.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 19010 Livernois Ave, Detroit, MI 48221
Phone: 313-863-9581    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.